Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Doxorubicin 60 / Cyclophosphamide 600 x 4 followed by Paclitaxel 80 / Trastuzumab 4 x 12, Breast Ca, adjuvant, Part B Cycle 1

Protocol-ID: 491 V1.1 (Mini), AC (DOXO60/CYCL600) x 4 followed by PACL80/TRAS4 x 12, Breast Ca, adj. B C1

Indication(s)

  • Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 01.04.2020